Journal Article
Research Support, Non-U.S. Gov't
Add like
Add dislike
Add to saved papers

Does the number of grafts influence surgeon choice and patient benefit of off-pump over conventional on-pump coronary artery revascularization in multivessel coronary artery disease?

BACKGROUND: It is not known whether surgeons preferentially assign patients requiring fewer grafts (1 to 3) to off-pump coronary artery bypass graft surgery (OPCABG) and those requiring many grafts (4 to 7) to conventional on-pump coronary artery bypass graft surgery (ONCABG), nor whether risk-adjusted outcomes are similar for OPCABG and ONCABG among patients receiving 1 to 3 and 4 to 7 grafts.

METHODS: Emory Hospitals' prospective database was retrospectively reviewed for 11,413 consecutive, isolated, primary coronary revascularization procedures between January 1997 and May 2005. Patients were divided into four groups: OPCABG 1 to 3 grafts (n = 3,187), OPCABG 4 to 7 grafts (n = 1,305), ONCABG 1 to 3 grafts (n = 3,279), and ONCABG 4 to 7 grafts (n = 3,642). A propensity score for surgery type was estimated from 39 risk factors. Multivariable logistic regression examined independent impact of surgery type and number of vessels grafted on outcomes. Computed interactions determined whether the effect of surgery type on risk-adjusted outcomes was consistent across groups.

RESULTS: Patients requiring 4 to 7 grafts had adjusted odds of receiving ONCABG 2.92 times higher than patients requiring 1 to 3 grafts (p < 0.001). The OPCABG patients had adjusted odds ratios of 0.53 for death (p = 0.007), 0.42 for stroke (p < 0.001), 0.51 for major adverse cardiac events (p < 0.001), and 0.71 for renal failure (p = 0.05) as compared with ONCABG patients. The interaction between OPCABG and number of vessels grafted was not statistically significant.

CONCLUSIONS: This study demonstrates that surgeons tend to perform OPCABG for patients requiring 1 to 3 grafts and ONCABG for those requiring 4 to 7 grafts. Off-pump CABG is associated with reduced adjusted risk of adverse outcomes compared with ONCABG. This benefit is consistent for patients requiring 1 to 3 or 4 to 7 grafts.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app